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fhere has been a proliferation of publications related to
ongenital heart disease in major cardiology journals with
ncreased numbers of excellent papers related to this topic.
his has made it more difficult to select only a relatively
mall number of the articles that can be critical to advance-
ents in the field.
As in the past, I have chosen to focus almost entirely on
he outcomes of management of the complex conditions
hat present to surgeons and cardiologists in this field.
ections chosen to report on include patients with tetralogy
f Fallot (T/F), transposition of the great arteries (TGA),
ypoplastic left heart syndrome (HLHS), Fontan surgery,
ardiac surgery in general, adult congenital heart disease
ACHD), and miscellaneous topics. Hopefully, these selec-
ions will be useful to those in the field and lead to further
esearch and development of new management strategies
hat will improve long-term outcomes.
etralogy of Fallot
damson et al. (1) present a detailed review of all papers
elated to pulmonary valve replacement (PVR), in T/F, and
he question of whether it improves right ventricular (RV)
unction. These authors reviewed 19 of 730 papers; their
earch represented the best evidence to answer the question.
he data indicate that PVR does improve RV function with
ssociated symptomatic benefit. The authors report consis-
ent reductions in RV end-diastolic and end-systolic vol-
mes with improvement in RV stroke volume. One study
lso showed improvement in left ventricular (LV) stroke
olume. They concluded that PVR improved clinical status
nd can be performed with low mortality. Unfortunately,
here remains a need for a more durable pulmonary valve.
Boni et al. (2) present current strategies in pulmonary
alve sparing T/F repair; with evaluation of RV/LV pressure
atios in the European Journal of Cardiothoracic Surgery.
reserving pulmonary valve integrity may offer a better
ong-term prognosis, despite a risk of residual stenosis.
hese authors studied 24 patients with T/F who underwent
eparative surgery with a valve sparing procedure (median
ge 8.1 months, range 1.1 to 86.6 months). Intraoperative
rom the Division of Cardiology, Vanderbilt Children’s Hospital, Nashville,g
ennessee. Dr. Graham has reported that he has no relationships to disclose.
Manuscript received July 27, 2010, accepted August 10, 2010.ost-repair echocardiography showed a right ventricular
ressure/left ventricular pressure (RVP/LVP) ratio0.70 in
patients (33%, group A) and 0.70 in 16 patients (67%,
roup B). There was neither early mortality, nor functional
r rhythm disturbances. One patient required reoperation
or residual stenosis at the annular level at 1 year. After a
edian follow-up of 32.8 months (range 0.6 to 73.1
onths), the RVP/LVP ratio decreased by 16% (p 0.001)
n all patients. In group A, the reduction was 28%, and in
roup B was 12%. A valve sparing strategy reduces pulmo-
ary regurgitation (PR), preserves RV function, and may
ecrease the incidence of late arrhythmias, which are deter-
inants of long-term outcome. These authors did accept a
airly high RVP/LVP pressure ratio in the operating room.
hether or not this will result in an improved long-term
esult is still unclear. The operation can be performed with
low mortality as shown here; follow-up studies should help
o solve the question of when this operation should be used.
levated RVP over the long term may result in decreased
V systolic  diastolic function.
Kanter et al. (3) report on symptomatic neonatal T/F:
epair or shunt? These authors studied 37 consecutive,
onrandomized symptomatic neonates with T/F or its
ariants including complete atrioventricular (AV) septal
efect or absent pulmonary valve (but excluding pulmonary
tresia) who had either a shunt (n  17) or primary repair
n  20). The shunted patients more commonly required
mergency operation (24% vs. 0%; p  0.036); otherwise,
he 2 groups were similar. One infant with pre-operative
owel ischemia died 1 day post-operatively after emergency
hunting. There were 2 late deaths 11 and 12 months
ost-operatively, both in primary repair patients. The 16
urviving shunted patients had T/F repair 216  99 days
fter the original shunt. The shunted patients had shorter
ntensive care unit and hospital stays for the first operation,
hich became equivalent when the second hospitalization
repair) values were added. The primary repair patients
ore frequently had a transannular patch and a tendency to
ore frequent delayed sternal closure. Four primary repair
20%) and 2 shunted (12.5%) patients required subsequent
ardiac operations after complete repair (pNS). Shunting
r primary repair of neonates with symptomatic T/F pro-
ided equivalent mortality and results. Shunted patients had
ewer transannular patch repairs despite having more emer-
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January 11, 2011:210–8 Year in Congenital Heart Diseaseay do well in terms of getting by with a lower right
entricular outflow tract (RVOT) pressure post-repair and
ess PR. A selective operative strategy in these infants
erhaps can decrease long-term RV dilation and PR.
ransposition of the Great Arteries
chwerzmann et al. (4) report on ventricular arrhythmias
nd sudden death (SD) in adults after a Mustard operation
or TGA. These authors studied the outcome of 149 adults
mean age 28  7 years) who had undergone a Mustard
peration for TGA. During a mean follow-up of 9  6
ears, sustained ventricular tachycardia (VT) and/or SD
ccurred in 9% (13 of 149) of the cohort. Sustained VT/SD
as more likely to occur in patients with associated ana-
omic lesions within New York Heart Association (NYHA)
unctional class III (hazard ratio [HR]: 9.8, 95% confi-
ence interval [CI]: 3.0 to 31.6) and with an impaired
ubaortic right ventricular ejection fraction (RVEF) (HR:
.2, 95% CI: 1.2 to 4.0). There was an inverse correlation of
he RVEF and QRS duration. Patients with a QRS
uration 140 ms were at the highest risk of sustained
T/SD (HR: 13.6, 95% CI: 2.9 to 63.4). Atrial tachyar-
hythmia was detected in 66 (44%) patients, but was not a
tatistically significant predictor of sustained VT/SD. These
uthors conclude that sustained VT/SD in adults after a
ustard operation for TGA are more common than pre-
iously described. Age, systemic ventricular function, and
RS duration are interrelated and are associated with
T/SD. A QRS duration140 ms may help to identify the
igh-risk patients. Systemic right ventricles do deteriorate
ith time even after quite successful atrial repair; some of
hese patients may be candidates for implantable
ardioverter-defibrillators.
Rutz et al. (5) report on RV absolute myocardial blood
ow (MBF) in complex congenital heart disease. These
uthors used myocardial contrast echocardiography (MCE)
o determine the myocardial microvascular density reflected
y relative myocardial blood volume (rBV). The study was
onducted to elucidate the relationship between the right
entricular hypertrophy (RVH) and myocardial microvas-
ular changes by quantitative MCE in patients with TGA
nd T/F. Three groups were included: 22 patients with
GA, 18 patients with T/F, and 22 healthy individuals
controls). MCE was performed at rest and during
denosine-induced hyperaemia. Hyperaemic septal rBV dif-
ered significantly between the groups and was the highest
n controls and the lowest in TGA. The ratio of hyperaemic
o baseline MBF, which differed significantly between the
roups, also was lowest in TGA versus T/F and controls.
yperaemic septal rBV, MBF, and myocardial blood flow
eserve (MBFR) showed a significant correlation with RV
ystolic function as determined by tricuspid annular systolic
xcursion. These data showed that relative MBF and flow
eserve in patients with systemic right ventricles is dimin-
shed. This abnormality has been shown previously, but this wtudy provides more data in this regard. Hopefully, there
ill be research in the future that will provide ways to
ncrease myocardial blood flow, particularly in patients with
ystemic right ventricles.
Tobler et al. (6) reviewed outcomes in young adult
urvivors of arterial switch operation (ASO) for TGA.
urvival of the 132 infants discharged from the hospital
fter ASO was 97% and 65 patients (mean age, 21 years)
ollowed at their institution; 17% had at least 1 clinically
ignificant cardiac lesion, including ventricular dysfunction,
alvular dysfunction, or arrhythmias. Residual lesions were
ore common in those who had had cardiac reinterventions
n childhood. In adulthood, 5 patients, (8%) had arrhythmia
equiring treatment, and 7 patients (11%) required reinter-
entions (5 reoperations and 2 pacemaker implantations).
ntervention for aortic valve regurgitation and aortic root
ilatation was not observed. Exercise capacity was reduced
n most adults after ASO.
Although most adults after ASO are well, and few have
esidual defects, there are subgroups who need further
ardiac intervention in childhood and who are at higher risk
or ventricular  valvular dysfunction and arrhythmias. The
utlook continues to look favorable compared with patients
ho have had Mustard or Senning repair versus ASO.
hese patients need follow-up to be sure that their coronary
lood flow is adequate and no other residual lesions that will
equire intervention in the future become evident.
Navabi et al. (7) report on the effect of ventricular septal
efect (VSD) enlargement on the outcome of Rastelli or
astelli-type repair of TGA; 49 patients had Rastelli
perations and were involved in a follow-up study divided
nto 2 groups: group A had VSD enlargement, and group B
id not have VSD enlargement. Median age and weight at
he time of the operation were 6 years and 17 kg, respec-
ively. The VSD was enlarged in 57% or 28 patients. VSD
nlargement was associated with a significantly statistical
elation with late ventricular dysfunction, arrhythmia, and
esidual VSD. Freedom from late death for those without
SD enlargement was 100% at 5 and 10 years of age, 83%
t 15 years. Those with VSD enlargement had 74% survival
t 5 years and 65% at 10 years. At a median follow-up of 4
ears, there were 12 late-onset deaths: 11 patients in the
roup with VSD enlargement and 1 in the group without.
SD enlargement increased the risk of late death as well as
he risk of ventricular dysfunction.
This group represents another way to change the right
entricle to the pulmonary ventricle and the left ventricle to
he systemic ventricle with TGA and VSD. These post-
astelli patients have been shown in the past to have
ecreased ventricular function and this study shows that
SD enlargement can contribute to this problem.
Hu et al. (8) report on double-root translocation for
ouble-outlet right ventricle with noncommitted ventricular
eptal defect (DORVncVSD) associated with pulmonary
tenosis (PS). These authors report 10 consecutive patients
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Year in Congenital Heart Disease January 11, 2011:210–8ean age of 48 months for DORVncVSD or subpulmonary
SD associated with PS. The VSD was repaired with a
atch, and VSD enlargement was done in 3 patients. The
ortic translocation was done with (n  4) or without (n 
) coronary reimplantation. The neopulmonary artery was
econstructed with a monocusp bovine jugular vein patch
n  8) or a homograft patch (n  2). The mean follow-up
nterval was 22 months. There were no early or late deaths,
nd no reoperations. Post-operative echocardiography
howed satisfactory hemodynamics of the reconstructed
iventricular outflow tract and ventricular function. One
atient had trivial aortic regurgitation (AR), and 4 patients
ad trivial or mild PR on follow-up. The early results
howed an improved outcome for DORVncVSD or DORV
ith subpulmonary VSD, associated with PS. Long-term
enefits need to be evaluated with a larger number of
atients and longer follow-up. This is a long and complex
peration; the mean bypass time was 311 min, and cross
lamp time was 219 min. Despite these data, there was no
ignificant ventricular dysfunction detected. The standard
astelli operation, which is the alternative operation, has
onsiderable difficulties with recurrent LV outflow track
bstruction and with ventricular function on follow-up. If
his new approach can be accomplished by other groups, it
hould lead to improved outcomes.
Lim et al. (9) report on biventricular repair for congeni-
ally corrected transposition of the great arteries (CCTGA).
hese authors studied 167 patients with CCTGA who
nderwent biventricular repairs. Physiological repairs were
erformed in 123 patients, and anatomic repairs in 44.
verage follow-up was 9 years. Overall survival was 83% at
5 years. In anatomic repair, LV training and RV dysfunc-
ion had a negative impact on survival, but bidirectional
avopulmonary shunt had a positive impact. The
eoperation-free survival was 10% at 22 years after physio-
ogical repair, and 46% at 15 years after anatomic repair.
reedom from any arrhythmia was 49% at 22 years after
hysiological repair, and 61% at 18 years after anatomic
epair. Freedom from systemic AV valve and ventricular
ysfunction as well as tricuspid valve and RV dysfunction
as significantly higher in anatomic repair than in physio-
ogical repair.
Although long-term results of biventricular repair were
atisfactory, patients who present with RV dysfunction can
e a high-risk group for anatomic repair and selection
riteria are particularly important. Anatomic repair is the
rocedure of choice for these patients if both ventricles are
dequate and ventricular dysfunction is only mild to mod-
rate and/or if the surgical technique is modified with the
elp of an additional bidirectional cavopulmonary shunt.
his paper adds to the body of information regarding
natomic repair. This is a long and difficult operation.
etraining of the LV is complex and fraught with danger of
iventricular failure. Tricuspid regurgitation (TR) should be
reated early, as late replacement of the tricuspid valve is
ften shown to lead to a marked decrease in RV function. dKollars et al. (10) report on CCTGA associated with TR.
his study was performed to determine the effect of LV
ressure on RV and LV geometry and the degree of TR.
erial echocardiograms were reviewed from 30 patients with
CTGA who underwent pulmonary artery banding to train
he morphologic left ventricle (n  14, age 0 to 12 years,
verage 1.1) or left ventricle-to-pulmonary artery conduit
lacement and ventricular septal defect closure in conjunc-
ion with physiological repair (n  16, age 0.1 to 23 years,
edian 3.3 years). After pulmonary artery banding, an
ncrease in LV systolic pressure equal to or greater than
wo-thirds systemic resulted in a decrease in TR from severe
o moderate. The percentage of patients with severe TR
ecreased from 64% to 18%. The RV sphericity index
ecreased, and the LV sphericity indexed increased. After
eft ventricle-to-pulmonary artery conduit placement, a
ecrease in LV pressure equal to or less than one-half
ystemic resulted in an increase in TR from none to mild.
his information was somewhat speculative in the past
bout the change in TR with the change in LV pressure and
eptal orientation. This is another way to improve TR in
oung patients with low LV pressures who can tolerate the
ulmonary artery banding. These patients may improve
onsiderably and may not require anything further for many
ears after this operation if it is successful in decreasing the
egree of TR and improving systolic function of the RV.
ypoplastic Left Heart Syndrome
hye et al. (11) present comparisons of shunt types in the
orwood procedure for single-ventricle lesions with sys-
emic ventricular outflow tract obstruction. This is a long-
waited study of patients who were randomly assigned to
ither the modified Blalock-Taussig (MBT) shunt or the
ight ventricle–pulmonary artery (RVPA) connection at 15
orth American centers. The primary outcome was death
r cardiac transplantation 12 months after randomization.
econdary outcomes included unintended cardiovascular
nterventions, RV size and function at 14 months, and
ransplantation-free survival until the last subject reached 14
onths of age. Transplantation-free survival 12 months
fter randomization was higher with the RVPA shunt than
ith the MBT shunt (74% vs. 64%, p  0.01). The RVPA
hunt group had more unintended interventions (p 0.003)
nd complications (p  0.002). RV size and function at the
ge of 14 months and the rate of nonfatal serious adverse
vents at the age of 12 months were similar in the 2 groups.
ata collected over a mean follow-up period of 33 months
howed a nonsignificant difference in transplantation-free
urvival between the 2 groups.
This is an outstanding achievement to develop this degree
f cooperation for a randomized trial in pediatric CV
urgery. Continuous surveillance of this cohort is needed to
etermine whether either of these shunts turns out to be
uperior over the long term and whether the RVPA group
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January 11, 2011:210–8 Year in Congenital Heart DiseaseRaja et al. (12) prepared a best-evidence topic in congen-
tal cardiac surgery questioning whether RV-PA shunt for
LHS compared with the MBT shunt is associated with
eleterious effects on ventricular performance. General lim-
tations included small numbers, nonrandomized design,
nd retrospective nature with failure of correlation of echo-
ardiographic indexes to clinical outcomes. The data did
how that there was no adverse effect of ventriculotomy on
entricular performance in patients with the Sano shunt in
he short and medium terms. It is clear that scars grow with
ime, and this question remains unanswered in the long
erm regarding effect on RV performance.
Patel et al. (13) report on the impact of noncardiac
ongenital and genetic abnormalities on outcomes in
LHS. These authors studied patients diagnosed with
LHS who underwent stage 1 Norwood (n 1,236), stage
superior cavopulmonary anastomosis (n 702), or stage 3
ontan (n  553). In-hospital mortality, post-operative
omplications, and length of stay were compared at each
tage between those with and without noncardiac genetic
efects. Stage 1 in-hospital mortality was higher (26% vs.
0%, p  0.04) with genetic defects. The mean post-
perative length of stay was 42 days versus 31 days (p 
.0001), and post-operative complications were significantly
ore prevalent in infants with noncardiac genetic defects.
arly hazard for death after Norwood was significantly
orse in infants with noncardiac defects. Chromosomal
efects were highly unfavorable: the early risk of death was
oubled, and Turner syndrome accounted for the majority
f chromosomal defects in this population. Mode of death
as rarely attributable to the noncardiac genetic defect.
hese data indicate a strong influence of noncardiac abnor-
alities on survival. Strategies to improve mortality in
nfants with noncardiac abnormalities should be explored.
resence of chromosomal defects, especially Turner syn-
rome, should enter decision-management options for pa-
ients and physicians.
Vogel et al. (14) reviewed fetal congenital diaphragmatic
ernia and LV hypoplasia in terms of outcome; of 125
atients diagnosed prenatally with congenital diaphragmatic
ernia (CDH), 111 had a left-sided defect. Of these, 85
ere live born, including 20 with congenital heart disease.
estational age-adjusted dimensions of fetal left heart
tructures, including aortic valve diameter, mitral valve
MV) diameter, LV long axis, LV short axis, and LV
olume were all smaller than normal. On average, the LV
ontributed 33% of combined ventricular output, lower than
he normal, 40% to 50%. The z-scores of left heart
tructures increased from the pre-natal echocardiogram to
he post-natal study, with average changes ranging from
.56 (aortic valve) to 1.39 (LV volume). Among live-born
atients, there was no association between prenatal left heart
-scores and postnatal survival. Hypoplasia of and reduced
ow through the left heart are common among fetuses with
eft-sided CDH. After birth and CDH repair, left heart
imensions generally normalize, with adequate size to fupport a biventricular circulation, even when there is very
ow flow through the left heart in mid and late gestation.
hese data should help physicians to continue to treat these
atients aggressively and not to deny their surgery because
f their LV size. Outcomes appear to depend more on lung
olume, which can correlate with post-natal survival.
McElhinney et al. (15) report on predictors of technical
uccess and postnatal biventricular outcome after in utero
ortic valvuloplasty for AS with evolving HLHS; 70 fetuses
nderwent attempted aortic valvuloplasty for critical AS
ith evolving HLHS. The median gestational age was 23
eeks. The procedure was technically successful in 52
etuses (74%). Relative to 21 untreated comparison fetuses,
ubsequent pre-natal growth of the aortic and mitral valves,
ut not the left ventricle, was improved after intervention.
ine pregnancies did not reach a viable term or preterm
irth. Seventeen patients had a biventricular circulation
ost-natally, 15 from birth. Larger left heart structures and
igher LV pressures at the time of intervention were
ssociated with biventricular outcome. A multivariable
hreshold scoring system was able to discriminate fetuses
ith a biventricular outcome with 100% sensitivity and
odest positive predictive value. Technically successful
ortic valvuloplasty alters left heart valvar growth in fetuses
ith AS and evolving HLHS and, in a subset of cases,
ppeared to contribute to a biventricular outcome after
irth. Fetal aortic valvuloplasty carries a risk of fetal demise.
etuses undergoing in utero aortic valvuloplasty with an
nfavorable multivariable threshold score at the time of
ntervention are very unlikely to achieve a biventricular
irculation post-natally.
These authors have continued to attempt to modify their
election criteria to determine which patients would be
andidates for a biventricular circulation with fetal interven-
ion. The multivariable threshold scoring system takes into
ccount the sizes of the aortic valve, MV, and LV, as well as
he LV pressure, and allowed the highly sensitive and
oderately specific identification of fetuses that survived
ost-natally with a biventricular circulation.
ontan Surgery
’Brien et al. (16) report on the nonfenestrated extracardiac
ontan procedure in a cohort of 145 patients. Hospital
urvival was 94.5% and takedown of the Fontan was
ecessary in 4 patients (2%); 3 of these 4 patients were also
perative deaths. Although female sex, cardiopulmonary
ypass time, and aortic cross-clamp time were found to be
ignificant in the univariate analysis, only cardiopulmonary
ypass time and sex were significant in the multivariate
nalysis for hospital survival. The late survival was 96% (131
f 137 patients) with a mean follow-up of 3.3 years. The
reedom from Fontan failure was 92% at 1 year, 89% at 5
ears, and 82% at 10 years. Stepwise logistic regression
ound cardiopulmonary bypass time to be a significant risk










































































































214 Graham Jr JACC Vol. 57, No. 2, 2011
Year in Congenital Heart Disease January 11, 2011:210–8n terms of going to a standard nonfenestrated extracardiac
ontan procedure. They utilized early extubation in the
perating room to enhance cardiac output. Of 8 early
ontan failures, 5 patients expired as a result of inadequate
ulmonary capacity. Of the remaining 3, 1 patient died
econdary to multisystem organ failure after operative malp-
rfusion, 1 secondary to air embolism, and 1 while awaiting
ransplantation due to diastolic dysfunction. Further inves-
igations are needed to provide data on pulmonary vascular
apacity to further increase the predictive value of pre-
perative studies. The incidence of supraventricular tachy-
ardia was low at 1 of 128 patients, or 0.8%. Although 16%
f the patients lost sinus rhythm in the follow-up period,
8% of that group had an ectopic atrial pacemaker. It is
isappointing to see the number of patients requiring home
rains for a median time of 21 days. Home treatment of the
ffusions was apparently well tolerated, and no significant
orbidity from this therapy was reported.
Salazar et al. (17) report on “Fenestration During Fontan
alliation: Now the Exception Instead of the Rule.” These
uthors report 226 consecutive patients who underwent
rimary Fontan palliation from 2008 to 2009 with the
elective use of Fontan fenestration. This technique has
volved with extensive use of an extracardiac conduit with
imited cardiopulmonary bypass and decreased fenestration
only 6% of patients had a fenestration used in the last year).
xtubation in the operating room was used if at all possible.
he mean hospital stay was 10 days. Survival to discharge or
0 days was 98%. Mean age and weight in this cohort was
years and 17 kg, respectively. These data support the
onfenestrated Fontan in the majority of patients unless
hey are high risk. These authors make the decision in the
perating room as to whether or not to fenestrate the
ontan patients. Patients known to be high risk such as
hose with single-lung Fontan palliation, severe AV valve
egurgitation, borderline pulmonary vascular resistance or
ranspulmonary gradient, or with poor ventricular function
ere more likely to have fenestration. Such high-risk
atients were obviously rare, and they may be better served
n many cases by transplantation. The discussion after
his paper included a comment that operating at high
ltitude, such as in Colorado, may be a requirement to use
enestration.
Rathod et al. (18) reported that myocardial fibrosis (MF)
dentified by cardiac magnetic resonance late gadolinium
nhancement (LGE) is associated with adverse ventricular
echanics and VT late after Fontan operation. These
uthors studied 90 patients with a mean age at study of 23
ears: 28% had positive LGE, and patients with LGE had
ower mean ejection fraction (45% vs. 56%), increased
edian end-diastolic volume, increased median ventricular
ass, higher frequency of regional wall motion abnormali-
ies, and higher frequency of nonsustained ventricular
achycardia (NSVT). In this cohort of late Fontan survivors,
F was common and associated with adverse ventricular
echanics and a higher prevalence of NSVT and SVT. It is alear that patients with definite LGE are a high risk for
ignificant problems with follow-up, including ventricular
ysfunction and ventricular arrhythmia. The real question is
ow to prevent LGE with management of these patients
rior to their Fontan operation. Hopefully, early volume
nloading and enhanced O2 saturations will prevent MF in
atients being seen now as infants.
Goldstein et al. (19) report on exercise capacity in
atients with a single ventricle receiving Fontan palliation.
hese authors studied 29 Fontan patients and 16 control
ubjects: Percentage of predicated peak oxygen consumption
VO2) was lower with supine exercise than with upright
xercise, and was decreased in Fontan patients as shown by
ther studies. Diastolic dysfunction was present in 57% of
he Fontan patients and was associated with a reduced
ercentage of predicted peak VO2 and supine peak work. Six
ontan patients who underwent supine exercise with in-
welling catheters failed to demonstrate the expected de-
rease in pulmonary vascular resistance characteristically
een with peak exercise. Supine exercise in Fontan patients
oes not result in an increased VO2 or oxygen pulse,
uggesting that venous return might not be the primary
imitation of exercise capacity in this population. Diastolic
ysfunction and relatively excessive peak-exercise pulmo-
ary vascular resistance might be more important factors in
ontan exercise limitation. These authors suggest that
ildenafil may help patients with Fontan palliation to
chieve better exercise performance. It has been suggested
hat chronic sildenafil use can be advantageous in improving
xercise performance in Fontan patients, but previous stud-
es have shown this only with acute administration of the
rug.
ardiac Surgery (General)
uang et al. (20) report on disproportionate growth of the
ricuspid valve after decompression of the right ventricle in
atients with pulmonary atresia and intact ventricular sep-
um. These authors studied 40 patients who underwent
nitial RV decompression for planned staged repair. The
nitial Z-value of the tricuspid valve diameter was obtained
he echocardiography-derived normal values. The late
-value was measured before definitive repair or the last
vailable Z-value, if definitive repair was not yet reached.
he mean initial tricuspid Z-value was 6.2  3.5. After
reatment, the mean Z-value was 6.0  3.4. Overall, the
ricuspid Z-values did not change. Individually, the change
n Z-value was larger than 2 in 11 (32%) patients and
maller than2 in 6. Increases in Z-value were significantly
ssociated with RVP/LVP ratio measured after initial pal-
iation and the initial tricuspid valve Z-value.
These findings support the possibility of neonates with
ery small tricuspid valves undergoing biventricular repair
fter RV decompression surgery. There have been previ-
us studies suggesting that tricuspid valves prior to
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January 11, 2011:210–8 Year in Congenital Heart Diseasehese authors found a number of patients who became
andidates for biventricular repair despite the initial
-values of 6.3. These data suggest that a very small
ricuspid valve may not be an indication for abandoning
ossible biventricular repair. The question remains as to
hether one can make the atrial defect slightly smaller
ith the initial RVOT opening to “force” blood across a
mall tricuspid valve and pulmonary outflow to enlarge
he RV long term. Obviously, this is a risky procedure
hat should be quantified in terms of the ability to pursue
his strategy in the long-term.
urgery for Ebstein’s Anomaly
alhotra et al. (21) report on selective RV unloading and
ovel technical concepts in surgery from Ebstein’s anomaly.
hese authors report on 57 non-neonatal patients who
nderwent Ebstein’s anomaly repairs at a median age of 8.1
ears. All were symptomatic in NYHA functional class II to
V. Pre-operative, 26 had mild to moderate cyanosis at rest,
nd a number of valve reconstructive techniques were used
hat differed substantially from those currently described.
idirectional Glenn (BDG) was performed in 31 patients
55%) who met specific criteria. No early or late deaths
ccurred. At the initial repair, 3 patients received a pros-
hetic valve. Four patients required reoperation for severe
R, and repeat repairs were successful in 2 patients. At
ollow-up (3 months to 6 years), all patients were acyanotic
nd in NYHA functional class I. TR was mild or less in 49
86%) and moderate in 6 (11%). Freedom from prosthesis
as 91% (52 of 57). Following a protocol using BDG for
entricular unloading in selected patients, these authors
eport a durable valve sparing repair using the techniques
escribed in terms of valve reconstructive surgery including
he “play it where it lies” approach to the tricuspid valve in
hich the reconstruction is performed at the functional
rifice instead of moving the valve to the anatomic tricuspid
nnulus. Avoidance of detachment and reimplantation of
alve leaflets and a limited plication performed only at the
evel of the displaced valve rather than complete plication of
he entire atrialized RV was used.
The question as to whether RV systolic function is really
ormal in any patients with Ebstein’s was brought up in the
iscussion of this paper. Hopefully, these authors will use
xercise data on further follow-up of their patients to show
vidence of good, long-term results.
Shinkawa et al. (22) report on the management and
ong-term outcome of 40 symptomatic patients with Eb-
tein’s anomaly in the neonatal period. There was no early
ntervention required in 16 of the 40 patients with a hospital
urvival of 94% (15 of 16) and no late mortality. The
emaining 24 patients underwent surgical intervention in
he neonatal period; a shunt alone was performed in 9
atients with an actuarial survival of 88.9% at 1 year and
6.2% at 5 and 10 years. For the patients undergoing
urgical intervention, survival estimates for the 11 patients Bith an RV exclusion procedure were 64% at 1, 5, and 10
ears, and 48% at 15 years compared with 25% at 1, 5, and
0 years for the 4 patients with tricuspid valve repair. All
ong-term survivors were in NYHA functional class I or II,
nd only 1 patient required ant arrhythmic medication.
hese authors suggest that optimally, neonates with symp-
omatic Ebstein’s anomaly can be successfully managed with
nly early prostaglandin without surgical intervention. For
hose patients who cannot be weaned from prostaglandin, a
ystemic/pulmonary (SP) shunt alone can be used if heart
ailure is absent. For patients with both cyanosis and heart
ailure necessitating tricuspid valve intervention in the
ewborn period, the data suggest that RV exclusion (tricus-
id valve closure with an SP shunt) results in the most
avorable outcome. Although tricuspid valve repair allows
or biventricular anatomy and remains an important part of
he surgeon’s armamentarium for older children, it is best
eserved for those neonates with the most favorable anatomy
ased on pre-operative and intraoperative assessment.
ortic Valve/Aortic Disease
liver et al. (23) report on risk of aortic root or ascending
orta complications (AACs) in patients with bicuspid aortic
alve (BAV) with and without coarctation of the aorta
COA). These authors report on 631 patients in whom
AV was diagnosed by echocardiography or surgical inspec-
ion. These were further subdivided into 2 groups according
o presence of an associated COA, AACs including aortic
neurysms (ascending aorta55 mm), and aortic dissection,
upture, or decreased perfusion. Patients with a BAV and
OA had a greater prevalence of AACs than those with an
solated BAV. The coexistence of COA was the only
ignificant predictor of AACs (odds ratio: 4.7, 95% CI: 1.5
o 15; p  0.01). The clinical and echocardiographic data
ere reviewed for 341 patients with BAV without an AAC
t baseline who had undergone serial examination 1 year
part. The mean follow-up was 7 years (interquartile range
as 3.5 to 10.2; total, 2,436 patient-years). A new AAC
ccurred in 13 patients, and the incidence of AACs was
.3/100 patient-years in the COA group versus 0.2/100
atient/years in the non-COA group. All acute aortic events
t follow-up occurred in patients with a BAV and COA.
he long-term incidence of AACs in patients with isolated
AV is low, but patients with BAV and associated COA
re at increased risk. These authors have shown that a BAV
arely has major AACs unless there is a COA present. Prior
tudies have shown that BAV and the tricuspid aortic valve
re equal in prevalence with surgery in older patients with
ACs. There is an ongoing debate about whether all
atients with BAV have AACs that are genetic in origin or
re due solely to hemodynamic stress imposed on the valve.
n this setting, surgical recommendations for patients with
arfan syndrome might not be applicable to patients with
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s present.
ther Important Papers
in et al. (24) report on a retrospective review on of 922
atients who had repair of VSD, AV septal defect, or T/F
ith a median follow-up of 4.1 years. The incidence of
elayed AV conduction block was 0.3% to 0.7%. Post-
perative AV conduction block developed in 21 of the 922,
eing transient, with return of conduction 3 days (1 to 14)
fter surgery in 13 and permanent, with pacemakers im-
lanted 10 days after surgery, in 8. There were 905 patients
t risk for delayed AV conduction block, 3 had second- or
hird-degree block at 2, 8, and 16 months after surgery.
wo of these 3 had transient post-operative block. For
solated VSDs, the incidence was 1 of 496 (0.2%). There
ere 8 late deaths at 31 months (7 to 45 months) after
urgery. Five had normal conduction at death, but for 3
atients, the conduction status at death could not be
etermined. Including these 3 patients as possible cases of
elayed AV block yields an incidence of 0.3% to 0.7%. The
ncidence of early AV conduction block requiring a pace-
aker was 0.9% and that of delayed AV conduction block
as 0.3% to 0.7%. Transient AV conduction block may be
marker for increased risk of delayed block. These data
ndicate that block after surgery for VSD is much less than
ecently reported for percutaneous VSD closure.
Shuhaiber et al. (25) report intraoperative assessment
fter pediatric cardiac surgical repair: initial experience with
-arm angiography. Hybrid operating rooms have been
ncreasingly used in selected high-risk patients. Angiograms
n the operating suite can offer useful data in selective
tudies that echocardiograms cannot duplicate. These au-
hors performed intraoperative angiographic analysis in 18
ases. Cases in which intraoperative surgical management
an be influenced by the results of the on-table angiograms
nclude complex shunt patency, coronary patency, pulmo-
ary artery anatomy, and conduit compression. Angiograms
an be useful in certain complex patients and may well
ecome a standard in the future in these types of patients to
void the time to confirm or refute any outstanding con-
erns during surgical intervention. Intraoperative angiogra-
hy should reduce the need for early post-operative cath-
terizations by alerting the surgeon to potential or actual
urgical concerns in a timely fashion.
dult Congenital Heart Disease
potowsky et al. (26) report on trends in hospitalizations
or adults with ACHD in the U.S. These authors used
ationally representative data from 1998 to 2005 to identify
atients 18 years of age admitted to an acute care hospital
ith an International Classification of Diseases-9th Revi-
ion code designating a CHD diagnosis. National estimates
f hospitalizations and total hospital charges by year were
alculated. The number of ACHD hospitalizations in- preased from 35,992  2,645 in 1998 to 72,656  5,258 in
005. During this period, the annual number of admissions
rew for both simple and complex diagnoses. The percent-
ge of admissions originating in the emergency department
42%) or involving cardiac surgery (18%) remained stable
uring the study period. The average patient age and
roportion of patients with 2 medical comorbidities also
ncreased. Mean hospital charges per hospitalization in-
reased by 127%, and the estimated total national charges
or these hospitalizations increased by 357% from $691
illion in 1998 to $3.16 billion in 2005. The number of
ospital admissions for ACHD in the U.S. more than
oubled between 1998 and 2005. Hospital charges attrib-
ted to these admissions have grown even more dramati-
ally. This is a primary result of several unrelated phenom-
na, most notably improvements in pediatric care and
oninvasive diagnostic testing. As a result of the increased
umber of adult patients with simple and complex CHD,
ealth care resources are straining to meet the needs of
urther planning for the care of these patients both in terms
f facilities and physicians is urgently needed.
Verheugt et al. (27) reported on all hospital admissions
rom 2001 to 2006 of 5,798 adult patients with congenital
eart disease with the mean age of 39 years from the Dutch
ational registry. Admission rate in these patients was high
nd exceeded the general Dutch population by 2 to 3 times;
his difference was more pronounced in the older age
roups. Altogether there were 8,916 admissions, 5,411 of
hich were for cardiovascular indications. Among cardio-
ascular admissions, referrals for arrhythmias were most
ommon at 31%. Of 4,926 interventions, 2,459 were car-
iovascular, most often reparative interventions or cardio-
ersion. Most noncardiovascular admissions were obstetric.
mong defects, univentricular heart and tricuspid atresia
ad the highest incidence and duration of admission. These
uthors again show the health care utilization and registry in
he adult patients with congenital heart is high and increases
ith age. Admission rates are at least 2 times higher than in
he general population, and most marked in the older age
roups.
Verheugt et al. (28) report on the mortality in ACHD
rom the Dutch registry. Of 6,933 patients, 197 died during
follow-up of 24,865 patient-years as compared with the
eneral population, there was excess mortality, particularly
n the young. Median age of death was 48 years. Of all
eaths, 77% had a cardiovascular origin; 45% were due to
hronic heart failure or sudden death. Age predicted mor-
ality, as did gender, severity of the defect, number of
nterventions, and number of complications. Several com-
lications predicted all-cause mortality beyond the effects of
ge, sex, and congenital heart disease severity (i.e., endocar-
itis, supraventricular arrhythmias, ventricular arrhythmias,
onduction disturbances, myocardial infarction, and pulmo-
ary hypertension). These risks were similar in patients
bove and below 40 years of age. Almost all complications
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eath. The vast majority die from cardiovascular causes.
omplications are equally hazardous in younger as in older
atients. This is another wake-up call in terms of these
atients. These patients need physicians that are acquainted
ith their anatomy and physiology and can provide the care
eeded. There is a need for training of these physicians in all
orners of the world.
iscellaneous
im et al. (29) report on successful repair of atrial septal
efect (ASD) with Eisenmenger syndrome after prolonged
ildenafil therapy. This patient underwent repair of an ASD,
fter treatment for 2 years with sildenafil and has been
onitored for 4 years after repair. This case supports a “treat
nd repair” approach using advanced pulmonary vasodilator
herapy that may be optimal in selected patients with
therwise inoperable severe pulmonary hypertension. This
ase can raise hope to some of these patients with severe
ymptoms secondary to pulmonary arteriopathy and associ-
ted CHD.
Ionescu-Ittu et al. (30) report on prevalence of severe
ongenital heart disease after folic acid fortification of grain
roducts, with a time trend analysis in Quebec, Canada.
hese authors report on data analyzed in 2 time periods,
efore and after fortification of grain products, specifically
our and pasta products with folate, in which they studied
he prevalence of severe congenital heart defects including
/F, endocardial cushion defects, univentricular hearts,
runcus arteriosus, or transposition complexes in the Quebec
dministrative databases. Among the 1,324,400 births in
uebec in 1990 to 2005, there were 2,083 infants born with
evere congenital heart defects, corresponding to an average
irth prevalence of 1.57/1,000 births. Time trend analysis
howed no change in the birth prevalence of severe birth
efects in the 9 years before fortification (rate ratio: 1.01,
5% CI: 0.99 to 1.03), whereas in the 7 years after
ortification, there was a significant 6% decrease per year
0.94 to 0.97). Public health measures to increase folic acid
ntake were followed by a decrease in the birth prevalence of
evere congenital heart defects. These findings support the
ypothesis that folic acid has a preventive effect on heart
efects. Hopefully, other data can be found to substantiate
his initial observation.
This is the first study, to my knowledge, to show that
hanges in intake of this common vitamin can change the
ncidence of congenital heart disease. It certainly has worked
or neural tube defects and, hopefully, can be shown in similar
tudies to have the same effect in congenital heart disease.
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